Search

Search Results
Results 4001 - 4010 of 5284 for Active site
  • Veletri
    Drug - 16 Feb 2026
    Consumer Medicine Information (CMI) about Veletri intended for persons living in Australia.
  • Uptravi
    Drug - 16 Feb 2026
    Consumer Medicine Information (CMI) about Uptravi intended for persons living in Australia.
  • Opsumit
    Drug - 16 Feb 2026
    Consumer Medicine Information (CMI) about Opsumit intended for persons living in Australia.
  • Abilify Maintena Pre filled Syringe
    Drug - 13 Feb 2026
    Consumer Medicine Information (CMI) about Abilify Maintena Pre filled Syringe intended for persons living in Australia.
  • Clindamycin Viatris
    Drug - 13 Feb 2026
    Consumer Medicine Information (CMI) about Clindamycin Viatris intended for persons living in Australia.
  • DBL Promethazine Hydrochloride
    Drug - 11 Feb 2026
    Consumer Medicine Information (CMI) about DBL Promethazine Hydrochloride intended for persons living in Australia.
  • M-M-R II
    Drug - 5 Feb 2026
    Consumer Medicine Information (CMI) about M-M-R II intended for persons living in Australia.
  • Taltz (reformulation)
    Drug - 29 Jan 2026
    Consumer Medicine Information (CMI) about Taltz (reformulation) intended for persons living in Australia.
  • Exploring Targeted Protein Degradation as a New Strategy to Tackle Antimicrobial Resistance
    News - 28 Jan 2026
    Targeted protein degradation presents a promising strategy to address antimicrobial resistance, focusing on innovative approaches for gram-negative bacteria.
  • Sogroya
    Drug - 20 Jan 2026
    Consumer Medicine Information (CMI) about Sogroya intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback